LivaNova (LIVN) Non-Current Debt (2015 - 2026)
LivaNova (LIVN) posted Non-Current Debt of $285.3 million for Q1 2026, down 24.15% sequentially from $376.1 million in Q4 2025, and down 54.58% YoY from $628.2 million in Q1 2025.
LivaNova (LIVN) Non-Current Debt (2015 - 2026) Analysis & Trends
LivaNova has reported Non-Current Debt for 12 years, with the latest figure at $285.3 million in Q1 2026.
- Quarterly Non-Current Debt fell 54.58% year-over-year to $285.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $285.3 million (down 54.58% YoY) and the FY2025 annual result came in at $376.1 million, down 40.02% from the prior year.
- Non-Current Debt fell to $285.3 million in Q1 2026 per LIVN's latest filing, from $376.1 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $628.2 million in Q1 2025 and troughed at $285.3 million in Q1 2026.
- A 5-year average of $510.8 million and a median of $541.8 million in 2023 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2022 and 2026: Non-Current Debt soared 129.09% in 2022, then slumped 54.58% in 2026.
- Over 5 years, Non-Current Debt stood at $518.1 million in 2022, then climbed by 13.11% to $586.0 million in 2023, then gained by 7.0% to $627.0 million in 2024, then plunged by 40.02% to $376.1 million in 2025, then slipped by 24.15% to $285.3 million in 2026.
- According to Business Quant data, Non-Current Debt over the past three periods registered $285.3 million, $376.1 million, and $349.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.11 Bn | 194.51 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Stryker | 129.85 Bn | 126.37 Bn | 4.50 Bn | 14.19 Bn |
| 3 | Medtronic | 119.93 Bn | 110.71 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 74.18 Bn | 73.64 Bn | 3.85 Bn | 10.92 Bn |
| 5 | Edwards Lifesciences | 52.54 Bn | 48.29 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.76 Bn | 32.81 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.25 Bn | 32.14 Bn | 2.18 Bn | 10.09 Bn |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn | 7.34 Bn |
| 9 | Steris | 23.29 Bn | 22.80 Bn | 684.20 Mn | 1.65 Bn |
| 10 | LivaNova | 4.33 Bn | 3.81 Bn | 273.67 Mn | 290.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 290.10 Mn |
| Mar 31, 2026 | 285.28 Mn |
| Dec 31, 2025 | 376.10 Mn |
| Sep 30, 2025 | 349.03 Mn |
| Jun 30, 2025 | 348.49 Mn |
| Mar 31, 2025 | 628.15 Mn |
| Dec 31, 2024 | 627.00 Mn |
| Sep 30, 2024 | 604.29 Mn |
| Jun 30, 2024 | 605.43 Mn |
| Mar 31, 2024 | 604.75 Mn |
| Dec 31, 2023 | 586.00 Mn |
| Sep 30, 2023 | 568.16 Mn |
| Jun 30, 2023 | 586.40 Mn |
| Mar 31, 2023 | 541.76 Mn |
| Dec 31, 2022 | 518.07 Mn |
| Sep 30, 2022 | 537.00 Mn |
| Jun 30, 2022 | 459.79 Mn |
| Mar 31, 2022 | 457.54 Mn |
| Dec 31, 2021 | 236.80 Mn |
| Sep 30, 2021 | 234.41 Mn |